usnic acid has been researched along with Disease Models, Animal in 8 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| " KU showed increased bioavailability compared with UA in the tumor, liver, and plasma of a CT26 syngeneic mouse tumor xenograft model after oral administration, as determined by LC-MS/MS analysis." | 5.48 | Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. ( Bae, WK; Choi, YJ; Chung, IJ; Gamage, C; Ha, HH; Hur, JS; Kim, H; Kim, KK; Kim, SK; Lee, JH; Lee, JY; Lee, KH; Paik, MJ; Park, MS; Park, SY; Taş, İ; Yang, Y; Yu, YH; Zhou, R, 2018) |
| "Hypertrophic scarring is a common condition in the Chinese population; however, there are currently no satisfactory drugs to treat the disorder." | 1.48 | Usnic acid inhibits hypertrophic scarring in a rabbit ear model by suppressing scar tissue angiogenesis. ( Guo, S; Lei, L; Ma, X; Song, B; Song, Y; Su, Y; Yu, Z, 2018) |
| " KU showed increased bioavailability compared with UA in the tumor, liver, and plasma of a CT26 syngeneic mouse tumor xenograft model after oral administration, as determined by LC-MS/MS analysis." | 1.48 | Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. ( Bae, WK; Choi, YJ; Chung, IJ; Gamage, C; Ha, HH; Hur, JS; Kim, H; Kim, KK; Kim, SK; Lee, JH; Lee, JY; Lee, KH; Paik, MJ; Park, MS; Park, SY; Taş, İ; Yang, Y; Yu, YH; Zhou, R, 2018) |
| "(+)-Usnic acid (1) is a common bioactive lichen-derived secondary metabolite with a characteristic dibenzofuran scaffold." | 1.46 | Usnic Acid Benzylidene Analogues as Potent Mechanistic Target of Rapamycin Inhibitors for the Control of Breast Malignancies. ( Akl, MR; Ebrahim, HY; El Sayed, KA; Elsayed, HE; Hill, RA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, CJ | 1 |
| Peng, W | 1 |
| Zhao, JH | 1 |
| Yang, HL | 1 |
| Qu, LL | 1 |
| Wang, C | 1 |
| Kong, LY | 1 |
| Wang, XB | 1 |
| Lee, S | 1 |
| Lee, Y | 1 |
| Ha, S | 1 |
| Chung, HY | 1 |
| Kim, H | 2 |
| Hur, JS | 2 |
| Lee, J | 1 |
| Cazarin, CA | 1 |
| Dalmagro, AP | 1 |
| Gonçalves, AE | 1 |
| Boeing, T | 1 |
| Silva, LMD | 1 |
| Corrêa, R | 1 |
| Klein-Júnior, LC | 1 |
| Pinto, BC | 1 |
| Lorenzett, TS | 1 |
| Sobrinho, TUDC | 1 |
| Fátima, Â | 1 |
| Lage, TCA | 1 |
| Fernandes, SA | 1 |
| Souza, MM | 1 |
| Song, Y | 1 |
| Yu, Z | 1 |
| Song, B | 1 |
| Guo, S | 1 |
| Lei, L | 1 |
| Ma, X | 1 |
| Su, Y | 1 |
| Yang, Y | 1 |
| Bae, WK | 1 |
| Lee, JY | 1 |
| Choi, YJ | 1 |
| Lee, KH | 1 |
| Park, MS | 1 |
| Yu, YH | 1 |
| Park, SY | 1 |
| Zhou, R | 1 |
| Taş, İ | 1 |
| Gamage, C | 1 |
| Paik, MJ | 1 |
| Lee, JH | 1 |
| Chung, IJ | 1 |
| Kim, KK | 1 |
| Kim, SK | 1 |
| Ha, HH | 1 |
| Araújo, HDA | 1 |
| Silva Júnior, JG | 1 |
| Saturnino Oliveira, JR | 1 |
| Helena M L Ribeiro, M | 1 |
| C Barroso Martins, M | 1 |
| Cavalcanti Bezerra, MA | 1 |
| Lima Aires, A | 1 |
| C P Azevedo Albuquerque, M | 1 |
| Melo-Júnior, MR | 1 |
| Pontes Filho, NT | 1 |
| Pereira, EC | 1 |
| Raposo Silva, DJ | 1 |
| Dos Anjos, JV | 1 |
| Falcão, EPS | 1 |
| Silva, NH | 1 |
| Menezes Lima, VL | 1 |
| Ebrahim, HY | 1 |
| Akl, MR | 1 |
| Elsayed, HE | 1 |
| Hill, RA | 1 |
| El Sayed, KA | 1 |
| Gupta, VK | 1 |
| Verma, S | 1 |
| Gupta, S | 1 |
| Singh, A | 1 |
| Pal, A | 1 |
| Srivastava, SK | 1 |
| Srivastava, PK | 1 |
| Singh, SC | 1 |
| Darokar, MP | 1 |
8 other studies available for usnic acid and Disease Models, Animal
| Article | Year |
|---|---|
Usnic acid derivatives as tau-aggregation and neuroinflammation inhibitors.
Topics: Alzheimer Disease; Animals; Benzofurans; Cell Line, Tumor; Disease Models, Animal; Dose-Response Rel | 2020 |
Anti-inflammatory effects of usnic acid in an MPTP-induced mouse model of Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents; Benzofurans; Brain; Disease Models, Animal; Dopaminergic Neurons; | 2020 |
Usnic acid enantiomers restore cognitive deficits and neurochemical alterations induced by Aβ
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; A | 2021 |
Usnic acid inhibits hypertrophic scarring in a rabbit ear model by suppressing scar tissue angiogenesis.
Topics: Animals; Benzofurans; Cell Line; Cicatrix; Disease Models, Animal; Female; Human Umbilical Vein Endo | 2018 |
Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzofurans; Biological Availability; Cell Lin | 2018 |
Usnic Acid Potassium Salt: Evaluation of the Acute Toxicity and Antinociceptive Effect in Murine Model.
Topics: Analgesics; Animals; Behavior, Animal; Benzofurans; Disease Models, Animal; Drinking Behavior; Feedi | 2019 |
Usnic Acid Benzylidene Analogues as Potent Mechanistic Target of Rapamycin Inhibitors for the Control of Breast Malignancies.
Topics: Animals; Apoptosis; Autophagy; Benzofurans; Benzylidene Compounds; Breast Neoplasms; Cell Proliferat | 2017 |
Membrane-damaging potential of natural L-(-)-usnic acid in Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Benzofurans; Cell Membrane; Colony Count, Microbial; Disease Models, | 2012 |